Project Grant R21AI180412

Award Date 7/1/24
Completion Date 6/30/26
Dollars Obligated $188K
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
East Lansing, MI 48824, USA
Similar Awards
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $192,500.00 to the University of South Alabama to investigate the mechanisms of central nervous system invasion by the Lyme disease pathogen, Borrelia burgdorferi. The research aims to: Determine the role of the blood-cerebrospinal fluid barrier as a site for B. burgdorferi and immune cell entry into the...
This $382,500 five-year Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855 Allergy and Infectious Diseases Research supports research at Washington State University to study the functional and mechanistic aspects of the Lyme disease spirochete's genetic factors encoded on plasmid LP17. The key objectives are to: 1) Establish the importance of genes BBD21 and BBD22 for controlling the copy number of Borrelia burgdorferi plasmids and the...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $191,250 to support research on the role of genetic factors in antigenic variation of the VlsE surface protein of the Lyme disease spirochete, Borrelia burgdorferi. The goal is to decipher the mechanistic details of cis-acting factors involved in VlsE expression and gene conversion, which is a key mechanism for...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $509,130 to the University of South Florida to conduct research on the global virulence regulatory network in the Lyme disease pathogen Borrelia burgdorferi (BB). The key objectives are to: 1) define the regulon (set of genes) controlled by the BosR regulator and characterize the contributions of BosR-regulated...
This $199,984 Project Grant awarded by the National Science Foundation (NSF) Engineering program (CFDA 47.041) aims to increase the fundamental understanding of the immune response to various Lyme disease antigens using bacterial outer membrane vesicles (OMVs) as a novel carrier system. The research objectives are to: 1) explore fusion proteins as a proof of concept to present full Borrelia burgdorferi (BB) antigens on OMVs, 2) determine the potential to express multiple BB antigen epitopes on...
This $167,076 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will support research into the role of resident synovial macrophages in the transition from Lyme arthritis to antibiotic-refractory Lyme arthritis. The key objectives are to: 1) quantify the integrity of the resident synovial macrophage intimal lining during ex vivo Borrelia burgdorferi...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $250,573 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to the University of Pittsburgh to investigate how host genetic variations impact the transmission and progression of Babesia microti infection, the primary cause of human babesiosis, a tick-borne infectious disease. The two-year project aims to leverage the Collaborative Cross mouse model to map quantitative trait loci (QTLs) associated with...
The National Science Foundation (NSF) awarded a $471,214 Project Grant under the Biological Sciences (CFDA 47.074) program to the Cary Institute of Ecosystem Studies, Inc. The grant supports long-term research on the dynamics between resource pulses, rodents, ticks, and Lyme disease risk in oak forests. The key products and services to be delivered include: Collecting new data on tick numbers and survival across different life stages, integrating this into models to forecast Lyme disease risk....
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a 2-year, $544,500 Project Grant (CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders) to the Texas Biomedical Research Institute to characterize a novel mouse model for studying the neurological impacts of Chikungunya virus infection. The research aims to determine the mechanisms by which Chikungunya virus infects the brain and evaluate whether the mouse model develops the...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $299,933 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to L2 Diagnostics LLC, a for-profit biomedical research company based in Woodbridge, Connecticut. The project aims to develop a novel therapeutic using a secretory leukocyte protease inhibitor (SLPI) to mitigate Lyme arthritis and post-treatment Lyme disease syndrome. The award period runs from July 8, 2024 to June 30, 2026....

A MURINE MODEL OF LYME NEUROBORRELIOSIS - PROJECT SUMMARY LYME DISEASE (LD), THE MOST PREVALENT TICK-BORNE ILLNESS IN THE US (~300,000-475,000 ANNUAL CASES), IS CAUSED BY SPIROCHETES OF BORRELIELLA BURGDORFERI (BB) SENSU LATO (S.L.) COMPLEX. WHEN EARLY LD DIAGNOSIS IS MISSED, IT IS LEFT UNTREATED AND LD BECOMES CHRONIC. HUMAN VACCINE IS UNAVAILABLE. ANTIMICROBIAL TREATMENT OF CHRONIC/PERSISTENT INFECTION IS OFTEN UNREWARDING. LD MAY LAST FOR YEARS, PRESENTING ITSELF AS SKIN LESIONS, ARTHRITIS, CARDITIS, AND/OR LYME NEUROBORRELIOSIS (LNB). BOTH CENTRAL (CNS) AND PERIPHERAL NERVOUS SYSTEMS (PNS) ARE AFFECTED, WHICH RESULTS IN HEADACHE, FATIGUE, MEMORY LOSS, DEPRESSION, FACIAL NERVE PALSY AMONG OTHERS. THE MAIN REASON FOR INCOMPLETE UNDERSTANDING OF LNB IS THE LIMITED AVAILABILITY OF ADEQUATE ANIMAL MODELS. NONHUMAN PRIMATES ARE THE ONLY MODEL THAT DEMONSTRATES SIMILARITIES TO CLINICAL MANIFESTATIONS OF HUMAN LNB. HOWEVER, ISSUES OF COST, REAGENTS AVAILABILITY, NON-REPRODUCIBLE GENETIC BACKGROUNDS, AND ETHICAL CONCERNS LIMIT THEIR USE. LABORATORY MOUSE STRAINS DO NOT DEVELOP NEUROLOGICAL CLINICAL SIGNS AND ENCEPHALITIS. THE CURRENT KNOWLEDGE GAP IS THE LACK OF SUITABLE MOUSE MODELS OF LNB. THE OVERALL OBJECTIVE IS TO DEVELOP MOUSE MODEL THAT WILL BE PERMISSIVE TO BB ENTRY INTO THE CNS/PNS, DEVELOP INFLAMMATORY LESIONS IN THE NEURAL TISSUES, AND EXHIBIT NEUROLOGICAL SIGNS. IN THE PRELIMINARY 3-YEAR-LONG STUDY, THE COLLABORATIVE CROSS (CC) RESOURCE (32 LINES; ~240 MICE) WAS EXTENSIVELY USED TO IDENTIFY THE MOUSE MODEL OF LNB. THE DATA SHOWED THAT 100% OF MICE OF CC LINE E, WHICH WERE INFECTED WITH BB FOR 6 MONTHS, INCLUDING THE MOUSE THAT EXHIBITED NEUROLOGICAL SIGNS UPON BB INFECTION, DEVELOPED SIGNIFICANT INFLAMMATORY LESIONS IN THE BRAIN, SPINAL CORD, AND/OR PERIPHERAL NERVES. IN THIS APPLICATION, IT IS PROPOSED TO TEST DIFFERENT NEUROTROPIC BB STRAINS USING CC LINE E WHOSE MICE SHOWED BB INFECTION-INDUCED INFLAMMATION IN THEIR NEURAL TISSUES UPON BB INFECTION. IT IS ALSO PROPOSED TO INCLUDE NEW 18 CC LINES THAT HAVE NOT BEEN TESTED, SO THAT A TOTAL OF 50 CC LINES (32+18) WILL BE USED TO IDENTIFY GENETIC FACTORS CONTRIBUTING TO LNB VIA QUANTITATIVE TRAIT LOCUS ANLAYSIS. THE FOLLOWING SPECIFIC AIMS WILL BE PURSUED: SA1: DETERMINE IF LINE E MICE INFECTED WITH DIFFERENT NEUROTROPIC STRAINS OF BB S.L. WILL PRODUCE DISTINCT LNB PHENOTYPES; SA2: LOCALIZE GENETIC FACTORS CONTRIBUTING TO LNB. THIS APPROACH IS INNOVATIVE AS THE CC RESOURCE HAS NEVER BEEN UTILIZED IN THE LD RESEARCH FIELD. IDENTIFYING A SINGLE CC LINE THAT CONSISTENTLY SHOWS THE PRESENCE OF INFLAMMATION AND/OR SPIROCHETES IN THE NEURAL TISSUES WILL BE CONSIDERED A SUBSTANTIAL ADVANCE IN THE FIELD OF LNB. THE MAPPING RESOLUTION IS EXPECTED TO IDENTIFY CAUSAL REGIONS WITH CONFIDENCE, AND THE NUMBER, EFFECT SIZES, AND RELATIONSHIP AMONG QTL IDENTIFIED WILL HELP GUIDE SUBSEQUENT INVESTIGATIONS AND PROVIDE THE FOUNDATION FOR A FUTURE R01 APPLICATION. THE PROPOSED RESEARCH IS SIGNIFICANT BECAUSE A MOUSE MODEL OF LNB WILL ALLOW THE SCIENTIFIC COMMUNITY TO STUDY THE LNB PATHOGENESIS IN MUCH GREATER DETAIL AND AND PROVIDE THE FOUNDATION FOR A R01 APPLICATIONS.

Posted 6/27/24, 12:00 AM